74 filings
Page 3 of 4
CORRESP
Coeptis Therapeutics Inc.
1 Dec 21
Correspondence with SEC
12:00am
UPLOAD
Coeptis Therapeutics Inc.
24 Nov 21
Letter from SEC
12:00am
4
David Mehalick
18 Nov 21
Coeptis Therapeutics / David Mehalick ownership change
2:00pm
1-A
Coeptis Therapeutics Inc.
18 Nov 21
Offering $12M in Equity
12:44pm
10-Q
2021 Q3
Coeptis Therapeutics Inc.
Quarterly report
15 Nov 21
3:45pm
D/A
Coeptis Therapeutics Inc.
12 Oct 21
$9M in equity, sold $5.52M, 42 investors
7:52am
8-K
Coeptis Therapeutics Inc.
1 Oct 21
Termination of a Material Definitive Agreement
12:00am
8-K
Coeptis Therapeutics Inc.
27 Aug 21
Termination of a Material Definitive Agreement
12:00am
8-K
Coeptis Therapeutics Inc.
19 Aug 21
Coeptis Therapeutics Partners with VyGen-Bio, Inc. to Co-develop Two Assets
12:53pm
10-Q
2021 Q2
Coeptis Therapeutics Inc.
Quarterly report
16 Aug 21
4:12pm
D/A
Coeptis Therapeutics Inc.
28 Jul 21
$6M in equity, sold $5.21M, 39 investors
11:34am
8-K
Coeptis Therapeutics Inc.
13 Jul 21
New Corporate Name and Updated Stock Ticker Symbol Highlight Company’s Brand Transformation
2:36pm
10-Q/A
2021 Q1
Coeptis Therapeutics Inc.
Quarterly report (amended)
18 May 21
4:25pm
10-Q
2021 Q1
Coeptis Therapeutics Inc.
Quarterly report
17 May 21
4:39pm
10-KT
Coeptis Therapeutics Inc.
11 May 21
Annual report (with FYE transition)
4:48pm
8-K
Coeptis Therapeutics Inc.
11 May 21
Entry into a Material Definitive Agreement
2:20pm
8-K/A
Coeptis Therapeutics Inc.
10 May 21
Completion of Acquisition or Disposition of Assets
7:47am
8-K
Coeptis Therapeutics Inc.
30 Apr 21
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:19pm
D
Coeptis Therapeutics Inc.
24 Mar 21
$6M in equity, sold $171K, 2 investors
11:21am
D
Coeptis Therapeutics Inc.
25 Feb 21
$0 in equity, 81 investors
12:03pm